Skip to main content
Sherin Shaaban, MD, PhD, FACMG
Medical Director: Pharmacogenomics, Molecular Genetics
Assistant Professor, University of Utah School of Medicine Education Doctorate Degree—Genetics, Okayama University Medical Degree—Mansoura University Fellowship—Clinical Molecular Genetics, Icahn School of Medicine at Mount Sinai Research Fellowship—Genetics, Boston Children’s Hospital Certifications/Affiliations American Board of Medical Genetics and Genomics Research Interests Validation and implementation of pharmacogenetics clinical testing Pharmacogenetics in precision medicine Molecular testing of rare inherited disorders Publications Christensen KD, Bell M, Zawatsky CLB, et al. Precision population medicine in primary care: the Sanford chip experience. Front Genet. 2021;12:626845. Jurgens JA, Barry BJ, Lemire G, et al. Novel variants in TUBA1A cause congenital fibrosis of the extraocular muscles with or without malformations of cortical brain development . Eur J Hum Genet . 2021;29(5):816-826. Baye JF, Petry NJ, Jacobson SL, et al. Malignant hyperthermia susceptibility: utilization of genetic results in an electronic medical record to increase safety . Pharmacogenomics . 2020;21(17):1207-1215. Whitman MC, Di Gioia SA, Chan WM, et al. Recurrent rare copy number variants increase risk for esotropia. Invest Ophthalmol Vis Sci. 2022;61(10):22.
Connect Sign In
